PROGRAM DESCRIPTION:

This 9.5 hour comprehensive Pharmacology Update Course explores recent trends and evidence-based outcomes involving pharmacotherapeutic choices and diagnostic decision-making in NP practice. Using a systematic approach, emerging trends of the latest pharmacotherapeutic agents, as well as controversies in infectious disease management are presented. Approved antimicrobials, drug resistance, rational use of both inpatient and outpatient antibiotics, as well as drug warnings are explored. Additionally, treatment updates for a variety of common adult problems and disorders including pneumonia, MRSA, viral dilemmas, STDs/STIs, immunizations and vaccinations are covered, incorporating case study trivial analyses throughout the course.
 

OBJECTIVES:

1. Identify recent trends and various pharmacologic controversies in the management of select disorders

2. Recognize current evidence-based outcomes impacting pharmacotherapy decisions in practice

3. State new and evolving pharmacologic management options for select conditions

4. Identify common reasons for prescription and prescribing errors

5. Highlight front-line prevention strategies for prescribing errors and polypharmacy

6. Discuss newer antimicrobial agents, vaccines and tests, including appropriate use for prevention and treatment of bacterial, viral and fungal infections

7. Describe current bioterrorism threats, prevention and containment methods

Part I

·        Emerging Trends

·        Are Drugs the Answer to An Old Problem?  What’s on the Horizon?

·        Pharmacologic Controversies in the Management of Common Adult Problems and Diagnoses

o       Cardiovascular and Metabolic Disease

o       Asthma

o       Gastrointestinal Disturbances

o       Pain

o       Hypertension

o       Other

·        Approved Pharmacotherapeutic Agents

·        WARNINGS:  What to Watch and Why

Part II
      ·        Men’s Health

·        Inflammatory Reproductive Disorders in Men

o       Epididymitis

o       Prostatitis

o       Balanitis

o       Benign Prostatic Hypertrophy 

o       Erectile Dysfunction

o       Premature Ejaculation

o       Delayed Ejaculation/Orgasm

Part III

·        STDs/STIs – What’s New?

Part IV

·        Emerging and Re-emerging Infectious Diseases

·        Approved Antimicrobials

·        Rational Use of Outpatient Antibiotics

·        Inpatient Antibiotic Controversies

·        Drug Resistance Update

·        Pharmacotherapeutic Management Update of Select Topics

o       Upper Respiratory Infections Community-Acquired Pneumonia (CAP)

o       Cellulitis

o       Community-Acquired Methicillin Resistant S. aureus (CA-MRSA)

o       Viral Dilemmas

o       Immunizations and Vaccinations:  Are You Up-to-Date?

o       Bioterrorism Threats:  From Nowhere to NOW HERE

Part V

·        Prescribing Problems and Nightmares 

·        Prescription and Prescribing Errors

•  Polypharmacy: The Spectrum and Front-line Options

·        Strategies to Improve Prescribing Practices

CONTINUING EDUCATION: Nurse Practitioners and Other Registered Nurses:  This program has been approved for 9.5 contact hours of continuing education (which includes ALL 9.5 hours as pharmacology credit) by the American Academy of Nurse Practitioners.
AANP Provider ID 081018.


Note: Costs for maintaining required continuing education may be tax deductible! Please consult with your tax advisor regarding your personal situation.